Indivior Pharmaceuticals Inc (INDV) ownership: Top institutional holder: BlackRock, Inc. ($565.17M). Insider activity: Net Seller (1 buys, 19 sells). SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| BlackRock, Inc. | 18542220.00 | $565.17M | 2026-03-31 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 7891819.00 | $240.54M | 2026-03-31 |
| OAKTREE CAPITAL MANAGEMENT LP | 6984102.00 | $212.88M | 2026-03-31 |
| VANGUARD GROUP INC | 5473891.00 | $196.40M | 2025-12-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 5586576.00 | $170.28M | 2026-03-31 |
| STATE STREET CORP | 4903993.00 | $149.47M | 2026-03-31 |
| Two Seas Capital LP | 4746510.00 | $144.67M | 2026-03-31 |
| MILLENNIUM MANAGEMENT LLC | 4595535.00 | $140.07M | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-06-11 | |
| Sell | null | 2026-06-08 | |
| Sell | null | 2026-05-13 | |
| Sell | null | 2026-05-13 | |
| Sell | null | 2026-05-13 | |
| Sell | null | 2026-05-13 | |
| Sell | null | 2026-05-13 | |
| Sell | null | 2026-05-13 |
Back to INDV overview · INDV earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.